MET and HGF

  • Number of citations of the paper that reports this interaction (PMID 1655405)
  • 97
  • Data Source:
  • HPRD (in vitro, in vivo)

MET

HGF

Gene Name MET proto-oncogene, receptor tyrosine kinase hepatocyte growth factor (hepapoietin A; scatter factor)
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Multiple sclerosis (severity) ( 19010793)
Protein-Protein Interactions 37 interactors: BAG1 CASP3 CBL CNR1 CTNNB1 CTTN DAPK3 DCN DNAJA3 EGFR FAS GAB1 GLMN GRB2 HGF HGS INPP5D INPPL1 ITGB4 MUC20 PCBD2 PIK3R1 PLCG1 PLXNB1 PTPN11 PTPRB PTPRJ RANBP10 RANBP9 SHC1 SMC1A SNAPIN SNX2 SPSB1 SRC STAT3 VAV1 16 interactors: ADAMTSL4 BRCA1 CLEC3B F11 FN1 HGFAC HPN KLKB1 LCN2 MEOX2 MET PLAU SDC1 SDC2 ST14 VTN
Entrez ID 4233 3082
HPRD ID 01280 00799
Ensembl ID ENSG00000105976 ENSG00000019991
Uniprot IDs B4DLF5 P08581 P14210
PDB IDs 1FYR 1R0P 1R1W 1SHY 1SSL 1UX3 2G15 2RFN 2RFS 2UZX 2UZY 2WD1 2WGJ 2WKM 3A4P 3BUX 3C1X 3CCN 3CD8 3CE3 3CTH 3CTJ 3DKC 3DKF 3DKG 3EFJ 3EFK 3F66 3F82 3I5N 3L8V 3LQ8 3Q6U 3Q6W 3QTI 3R7O 3RHK 3U6H 3U6I 3VW8 3ZXZ 3ZZE 4AOI 4AP7 4DEG 4DEH 4DEI 4EEV 4GG5 4GG7 4K3J 1BHT 1GMN 1GMO 1GP9 1NK1 1SHY 1SI5 2HGF 2QJ2 3HMS 3HMT 3HN4 3MKP 3SP8 4K3J
Enriched GO Terms of Interacting Partners?
Tagcloud ?
basophil  basophils  c5a  ccr2  ccr3  chains  chemoattractant  chemotactic  continuous  continuously  cxcr1  cxcr2  eotaxin  express  fmlp  formyl  granulocyte  hardly  leu  leukotrienes  lt  ltc4  macrophage  mcp  mcp1  mediate  migratory  phe  unrelated  weakly 
amifostine  anticancer  benefits  csf  cytoprotective  decitabine  demethylating  developments  emerging  gm  granulocyte  hematologic  hematopoietic  hgfs  improvements  includes  infectious  introduced  issues  keratinocyte  kgf  prophylactic  renewed  risks  supportive  thrombopoietin  topics  transfusional  transfusions 
Tagcloud (Difference) ?
basophil  basophils  c5a  ccr2  ccr3  chains  chemoattractant  chemotactic  continuous  continuously  cxcr1  cxcr2  eotaxin  express  fmlp  formyl  hardly  leu  leukotrienes  lt  ltc4  macrophage  mcp  mcp1  mediate  migratory  phe  unrelated  weakly 
amifostine  anticancer  benefits  csf  cytoprotective  decitabine  demethylating  developments  emerging  gm  hematologic  hematopoietic  hgfs  improvements  includes  infectious  introduced  issues  keratinocyte  kgf  prophylactic  renewed  risks  supportive  thrombopoietin  topics  transfusional  transfusions 
Tagcloud (Intersection) ?
granulocyte